RTTNews盘后汇总多只生物科技股当日大涨及已披露催化

Top Biotech Gainers: SPRC On Watch, AVTR, NEO Boost Full-Year Outlook, SMTI Scooped Up
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Blockchain
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Corp. News
Market News
Health News
Entertainment News
Music News
TODAY'S TOP STORIES
By
Prabha Kurup
✉
|
Published:
7/29/2026 11:40 PM ET
Follow Us
Join Us
Add
as your preferred news source on Google
Add Now
Today's top biotech gainers include SciSparc, after its subsidiary successfully completed internal validation of a proprietary quantum sampling platform designed to analyze clinical trial data; Avantor, following the release of its second-quarter financial results and an upbeat outlook; and NeoGenomics, after raising its full-year guidance, among others.
Read on…
SPRC Achieves Quantum Analytics Milestone
SciSparc Ltd. (
SPRC
) led the pack of gainers on Wednesday following the announcement that its subsidiary NeuroThera Labs Inc. (TSXV: NTLX) has successfully completed internal validation of its proprietary quantum sampling platform for analyzing clinical trial data.
The platform is being advanced by CliniQuantum, a quantum
technology
initiative focused on developing proprietary computational solutions for complex clinical trial data analysis. NeuroThera holds a 54.01% ownership interest in CliniQuantum.
SPRC closed Wednesday's trading at $9.09, up 70.54%.
AMIX on Watch
Autonomix Medical Inc. (
AMIX
), a development-stage medical device company focused on advancing technologies for sensing and treating disorders of the nervous system, was up over 66% on no specific news.
As of July 28, 2026, the company had approximately $5.1 million in cash and 971,043 shares of common stock outstanding, including shares issued through its recent warrant inducement completed on July 13, 2026.
A 1-for-21 reverse stock split of its common stock was implemented on June 24, 2026.
AMIX closed Wednesday's trading at $4.57, up 66.18%.
AVTR Boosts Full-Year Outlook
Avantor Inc. (
AVTR
), a global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, was up over 15% on Wednesday, following its second-quarter financial results and upbeat outlook.
For the three months ended June 30, 2026, the company reported net sales of $1.69 billion, up 0.5% from the second quarter of 2025. Excluding the positive impact of foreign currency translation, organic net sales declined 0.4%. Meanwhile, net income fell to $38.1 million from $64.7 million in the same period last year. Adjusted net income also declined to $143.3 million from $161.2 million a year earlier.
For full-year 2026, the company increased its adjusted EPS guidance to $0.80 - $0.83 from $0.77 - $0.83 and improved its organic revenue growth outlook to -0.5% to +0.5% from -2.5% to -0.5%. The company's adjusted EPS was $0.90, and net sales were $6.55 billion in 2025.
AVTR closed Wednesday's trading at $14.38, up 15.78%.
NEO Upbeat on Growth, Raises Guidance
NeoGenomics Inc. (
NEO
), a provider of oncology diagnostic solutions that support precision medicine, was among the day's top gainers following the release of its second-quarter 2026 financial results and an upward revision to its full-year outlook.
Consolidated revenue for the second quarter of 2026 was $202 million, an increase of 11% over the same period in 2025. Net income for the quarter was $2 million compared to a net loss of $45 million for the second quarter of 2025. The latest quarter's results included an $11 million gain from debt extinguishment.
For full-year 2026, NeoGenomics raised its consolidated revenue guidance to the $802 million - $806 million range, up from its previous forecast of $797 million - $803 million. The company also narrowed its projected net loss range to $34 million - $42 million from the previous estimate of $50 million - $63 million. In 2025, the company reported a net loss of $108 million and consolidated revenue of $727 million.
NEO closed Wednesday's trading at $15.27, up 13.96%.
ALVO Soars as FDA Concludes Reykjavik Facility Inspection
Shares of Alvotech (
ALVO
) jumped more than 13% after the company announced that the FDA has concluded the inspection of its manufacturing facility in Reykjavik, Iceland, conducted in May 2026. The FDA has confirmed the inspection classification of the manufacturing site is Voluntary Action Indicated (VAI).
The company's Biologics License Application for AVT05, a proposed biosimilar to Simponi and Simponi Aria, was turned down by the FDA last November, citing issues with the manufacturing facility in Reykjavik, Iceland.
The Biologics License Applications (BLAs) for AVT05 and *AVT06 were resubmitted by the company to the FDA as recently as this June. *AVT06 is a proposed biosimilar to Eylea.
The company's AVT16, a proposed interchangeable biosimilar to Entyvio, indicated for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease, is also under FDA review.
ALVO closed Wednesday's trading at $3.53, up 13.87%.
SMTI To Be Acquired by MDXG
Sanara MedTech Inc. (
SMTI
) has agreed to be acquired by MiMedx Group, Inc. (MDXG) in a cash-and-stock transaction valued at $35 per Sanara share, representing a total enterprise value of approximately $350 million.
Under the definitive merger agreement, Sanara shareholders will receive $33.00 in cash plus 0.4735 shares of MIMEDX common stock for each Sanara share they own. Based on MIMEDX's average closing price of $4.22 over the five trading days ending July 28, 2026, the stock portion is valued at approximately $2.00 per Sanara share.
The transaction is expected to close by the end of this year.
SMTI closed Wednesday's trading at $30.25, up 13.55%.
LBRX Secures $150 Mln Financing
Shares of LB Pharmaceuticals Inc. (
LBRX
) gained more than 11% on Wednesday following the announcement of a private placement.
The company entered into a securities purchase agreement with institutional investors to sell approximately 3.58 million shares of common stock and pre-funded warrants to purchase up to 715,513 additional shares in the private placement. The shares are being sold at $34.94 per share, while the pre-funded warrants are priced at $34.9399 each.
The company expects the gross proceeds from the private placement to be approximately $150 million.
Recently, the company accelerated the timeline for reporting topline results from its Phase 3 NOVA-2 trial of LB-102 in schizophrenia. Topline results from the pivotal trial are now expected in the first half of 2027, earlier than its previous guidance of the second half of 2027.
A pre-NDA meeting with the FDA is expected to be held in the second half of 2027 following the data readout.
A Phase 2 trial of LB-102 in bipolar depression, dubbed ILLUMINATE-1, and a Phase 2 trial of LB-102 in adjunctive MDD are also ongoing.
The company expects to report topline data from its bipolar depression trial in the first quarter of 2028 and from its adjunctive major depressive disorder (MDD) trial in the first half of 2029.
LBRX closed Wednesday's trading at $39.00, up 11.62%.
Did you know?
Medical students often use grapes to practice suturing skills and improve precision - the reason grapes' thin, fragile skin provides a simple but effective model for learning how to handle delicate tissue with accuracy and control.
For comments and feedback contact: editorial@rttnews.com
Business News
Biotech Stocks Facing FDA Decision In July 2026
Biotech Stocks Facing FDA Decision In June 2026
Biotech Stocks Facing FDA Decision In May 2026
Previous Story
Next Story
Latest Updates on Middle East War
US Intensifies Attacks On Iran In Retaliation
July 30, 2026 06:00 ET
U.S. Dollar Slides As Fed Holds Interest Rates Amid Renewed Middle East Conflict
July 29, 2026 17:00 ET
Canadian Stocks Tumble Amid Fresh U.S.-Iran Escalation, Fed Interest Rate Decision
July 29, 2026 16:35 ET
Crude Oil Skyrockets After Iran Targets Jordan, U.S.-Saudi Forces Hit Iraq
July 29, 2026 14:38 ET
U.S. Dollar Slips As Easing Crude Oil Prices Lower Fed Rate Hike Expectations
July 28, 2026 17:00 ET
View More
FDA Decisions August 2026: Key PDUFA Dates Biotech Investors Are Watching | RTT BIOTECH NEWS
July 30, 2026 04:24 ET
The August 2026 FDA calendar features several important PDUFA decisions that could influence the biotech sector, healthcare innovation, and investor sentiment.
In this video, we break down five major FDA decisions expected in August 2026, including the therapies, companies, and diseases under review:
View More Videos
RELATED NEWS
NeoGenomics Q2 Revenue Improves 11%; Lifts FY26 Outlook; Shares Jump
Latest Updates on COVID-19
KFF Poll Finds AI Health Chatbot Users More Likely To Believe Vaccine Myths
July 01, 2026 14:27 ET
Editor's Pick
Most Read
Most Emailed
Xerox Stock Up 26% On Q2 Turnaround, Raised FY26 Outlook
July 30, 2026 08:42 ET
Automatic Data Processing Sees Growth In FY27 - Update
July 29, 2026 07:20 ET
GE HealthCare Stock Up 13% On Strong Q2 Profit & Orders, Positive Outlook
Boston Scientific Trims FY26 Outlook - Update
July 29, 2026 06:50 ET
Humana Q2 Profit Climbs, Cuts FY26 EPS Outlook, Backs Adj. Earnings, Revenue View; Stock Down
July 29, 2026 06:44 ET
Boeing Q4 Net Loss Narrows, Revenues Rise 8%
July 28, 2026 08:03 ET
Coca-Cola Boosts FY26 Outlook - Update
July 28, 2026 07:24 ET
UPS Lifts FY26 Outlook, Despite Weak Q2 Profit
July 28, 2026 07:09 ET
Philips Stock Drops On Weak Q2 Orders, Despite Profit Growth, Positive Outlook
July 28, 2026 06:01 ET
AstraZeneca Q2 Pre-tax Profit Down, But EPS Rise; Backs Positive FY26 View
July 27, 2026 04:19 ET
Ecolab Raises 2026 Earnings Guidance
July 28, 2026 08:33 ET
ProStar Holdings Appoints Michael Wolff As CEO, Succeeding Founder Page Tucker; Shares Down
July 27, 2026 08:34 ET
Expand Energy To Buy Twin Eagle For $1.25 Bln
July 27, 2026 07:49 ET
Carpenter Technology CEO Brian Malloy Passes Away; Tony Thene Named CEO
July 27, 2026 08:18 ET
Argenx To Buy Forte Biosciences In Around $2.2 Bln Cash Deal; Forte Biosciences Shares Climb
July 27, 2026 01:24 ET
Sanofi Q2 Net Profit Plunges, Business Profit Climbs On Strong Sales; Lifts FY26 Outlook
July 30, 2026 02:02 ET
Virtuix Says Tesla Buys Simulation System For Optimus Robots; Shares Tumble
July 27, 2026 11:17 ET
Luxfer Holdings To Be Bought By Wynnchurch Capital For $17.37/Share
July 27, 2026 08:51 ET
HYBE Q2 Earnings Jumps; Shares Fall 9%
July 28, 2026 02:05 ET
Siemens, NVIDIA Expand Partnership To Boost AI-Powered EDA
July 27, 2026 01:46 ET
SK Group And NVIDIA Expand $500 Bln+ AI Factories And Memory Partnership
July 25, 2026 01:30 ET
Perfect Corp. Q2 Profit Climbs
July 27, 2026 06:39 ET
NAVER, NVIDIA And Brookfield Plan 200MW Expansion Of Korea's AI Factory Infrastructure
July 25, 2026 01:52 ET
Rocket Lab Awarded $266 Mln Multi-launch Contract With U.S. Space Force, Shares Up
July 27, 2026 06:46 ET
Microchip Technology To Acquire Hailo
July 25, 2026 02:16 ET
Bank Of Hawaii Corporation Profit Rises In Q2
July 27, 2026 06:56 ET
Kuwait Oil Co. Signs $16 Bln Pipeline Infrastructure Partnership With Blackstone, Brookfield And KKR
July 25, 2026 02:42 ET
First Farmers And Merchants Corporation Reports Increase In Q2 Profit
July 27, 2026 07:07 ET
Trip.com Fined By SAMR For Online Hotel Booking Abuses
July 25, 2026 06:18 ET
HBT Financial, Inc. Q2 Income Advances
July 27, 2026 07:14 ET
Everbright Digital Prices Public Offering Of 4.293 Mln Ordinary Shares At $1.88/Shr
July 26, 2026 12:05 ET
Lakeland Financial Corp. Reports Rise In Q2 Profit
July 27, 2026 07:21 ET
Editors Pick
Loading...
Copyright © 2026 RTTNews. All rights reserved.
By using this site, you agree to the
Terms of Service
.
About Us
Privacy
Sitemap